rs25680
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001242.5(CD27):c.175G>A(p.Ala59Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.22 in 1,613,860 control chromosomes in the GnomAD database, including 41,005 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001242.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD27 | NM_001242.5 | c.175G>A | p.Ala59Thr | missense_variant | 2/6 | ENST00000266557.4 | NP_001233.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD27 | ENST00000266557.4 | c.175G>A | p.Ala59Thr | missense_variant | 2/6 | 1 | NM_001242.5 | ENSP00000266557.3 |
Frequencies
GnomAD3 genomes AF: 0.194 AC: 29458AN: 152006Hom.: 3008 Cov.: 31
GnomAD3 exomes AF: 0.191 AC: 47909AN: 251384Hom.: 5234 AF XY: 0.200 AC XY: 27158AN XY: 135862
GnomAD4 exome AF: 0.222 AC: 325207AN: 1461736Hom.: 38000 Cov.: 34 AF XY: 0.225 AC XY: 163421AN XY: 727180
GnomAD4 genome AF: 0.194 AC: 29443AN: 152124Hom.: 3005 Cov.: 31 AF XY: 0.191 AC XY: 14180AN XY: 74370
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 10, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Nov 12, 2023 | This variant is classified as Benign based on local population frequency. This variant was detected in 25% of patients studied by a panel of primary immunodeficiencies. Number of patients: 24. Only high quality variants are reported. - |
Lymphoproliferative syndrome 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at